Abraham et al., "Antiarrhythmic Properties of Tetrodotoxin Against Occlusion-Induced Arrhythmias in the Rat: A Novel Approach to the Study of the Antiarrhythmic Effects of Ventricular Sodium Channel Blockade," J. Pharmacol. Exp. Ther. 251:1166-1173, 1989. |
Alzheimer and Ten Bruggencate, "Nonopioid Actions of the .kappa.-Opioid Receptor Agonists, U 50488H and U 69593, on Electrophysiologic Properties of Hippocampal CA3 Neurons in Vitro," J. Pharmacol. Exp. Ther. 255:900-905, 1990. |
Clark et al., "Highly Selective .kappa. Opioid Analgesics. Synthesis and Structure-Activity Relationships of Novel N-[2-Aminocyclohexyl)aryl]acetamide and N-[(2-Aminocyclohexyl)aryloxy]acetamide Derivatives," J. Med. Chem. 31:831-836, 1988. |
Clark et al., "PD117302: a selective agonist for the .kappa.-opioid receptor," Br. J. Pharmacol. 93:618-626, 1988. |
Curtis and Walker, "Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia," Cardiovasc. Res. 22:656-665, 1988. |
Halfpenny et al., "Highly Selective .kappa.-Opioid Analgesics. 2. Synthesis and Structure-Activity Relationships of Novel N-[(2-Aminocyclohexyl)aryl]acetamide Derivatives," J. Med. Chem. 32:1620-1626, 1989. |
Halfpenny et al., "Highly Selective .kappa.-Opioid Analgesics. 3. Synthesis and Structure-Activity Relationships of Novel N-[2-(1-Pyrrolidinyl)-4- or -5-substituted-cyclohexyl]arylacetamide Derivatives," J. Med. Chem. 33:286-291, 1990. |
Howard and Walker, "Electrical Stimulation Studies with Quinacainol, a Putative 1C Agent, in the Anaesthetised Rat," Proc. West. Pharmacol. Soc. 33:123-127, 1990. |
Hunter et al., "CI-977, a novel and selective agonist for the .kappa.-opioid receptor," Br. J. Pharmacol. 101:183-189, 1990. |
Leighton et al., "Pharmacological profile of PD 117302, a selective .kappa.-opioid agonist," Br. J. Pharmacol. 92:915-922, 1987. |
Ma et al., "Synthesis and analgesic activity of analogs of U-50488, an opiate kappa-agonist," Chemical Abstracts 117::48285, p. 906, 1992. |
Meecham et al., "An in vitro profile of activity for the (+) and (-) enantiomers of spiradoline and PD117302," Eur. J. Pharmacol. 173:151-157, 1989. |
Penz et al., "A New ECG Measure (RSh) for Detecting Possible Sodium Channel Blockade in Vivo in Rats," J. Pharmacol. Methods 27:51-58, 1992. |
Pugsley et al., "Antiarrhythmic effects of U-50, 488H in rats subject to coronary artery occlusion," Eur. J. Pharmacol. 212:15-19, 1992. |
Pugsley et al, "Cardiovascular actions of the .kappa.-agonist, U-50, 488H, in the absence and presence of opioid receptor blockade" Br. J. Pharmacol. 105:521-526, 1992. |
Pugsley et al., "Electrophysiological and antiarrhythmic actions of the .kappa. agonist PD 129290, and its R,R(+) -enantiomer, PD 129289," Br. J. Pharmacol. 110:1579-1585, 1993. |
Pugsley et al., "Cardiovascular Actions of U50, 488H, and Related Kappa Agonists," Cardiovascular Drug Reviews 11:151-164, 1993. |
Sarne et al., "Anti-arrhythmic activities of opioid agonists and antagonists and their stereoisomers," Br. J. Pharmacol. 102:696-698, 1991. |
Singh et al., "The anticonvulsant action of CI-977, a selective .kappa.-opioid receptor agonist: a possible involvement of the glycine/NMDA receptor complex," Eur. J. Pharmacol. 191:477-480, 1990. |
Sitsapesan and Parratt, "The effects of drugs interacting with opioid receptors on the early ventricular arrhythmias arising from myocardial ischaemia," Br. J. Pharmacol. 97:795-800, 1989. |
Szmuszkovicz and Von Voigtlander, "Benzeneacetamide Amines: Structurally Novel Non-M.mu. Opioids," J. Med Chem. 25:1125-1126, 1982. |
Von Voigtlander et al., "U-50,488: A Selective and Structurally Novel Non-Mu (Kappa) Opioid Agonist," J. Pharmacol. Exp. Ther. 224:7-12, 1983. |
Wong et al., "Effects of Drugs Interacting with Opioid Receptors During Normal Perfusion or Ischemia and Reperfusion in the Isolated Rat Heart-an Attempt to Identify Cardiac Opioid Receptor Subtype(s) Involved in Arrhythmogenesis," J. Mol. Cell. Cardiol. 22:1167-1175, 1990. |